In honor of the “International Diabetes Awareness Day” and the 100-year anniversary of the discovery of insulin, Kadimastem opened the trade this morning at the Tel Aviv Stock Exchange.
“What a privilege it was to ring the bell, not only to open trading but to spotlight diabetes and the efforts being made to cure this condition. Kadimastem is working hard to put an end to diabetes and to improve the lives of the millions of people living with it . Our innovative stem cell derived Cell Therapy product IsletRx, proved its efficacy in our Pre-Clinical trials and we recently had a meeting with the FDA’s INTERACT Committee advancing our clinical program.” Asaf Shiloni, CEO of Kadimastem.
Photographer: Yoray Liberman
(Right to left): Kadimastem’s Professor Ariel Revel, Chairman of the Board Ronen Twito and CEO Asaf Shiloni join in the opening of trading on TASE, November 14, 2021.